Skip to main content
. 2024 Mar 4;16(5):1047. doi: 10.3390/cancers16051047

Table 2.

Perioperative variables: ASA = American Society of Anesthesiologists; BMI = body mass index; CCI = Charlson’s comorbidity index; CT = computed tomography; IQR: interquartile range; SD = standard deviation.

Variables
Number of patients 13
Age, yrs., mean (SD) 65 (12)
BMI (kg/m2), mean (SD) 26.4 (4.4)
CCI, median (IQR) 2 (2–3)
ASA score, median (IQR) 2 (1–2)
CT lesion size, mm., mean (IQR) 31 (22–41)
Clinical stage, no. (%)

  • cT1a

 8 (61.5)

  • cT1b

 3 (23.1)

  • >cT2

 2 (15.4)
Tumor location, no. (%)

  • Upper pole

 4 (30.8)

  • Mesorenal

 6 (46.2)

  • Lower pole

 3 (23.1)
Tumor growth pattern, no. (%)

  • >50% Exophytic

 2 (15.4)

  • <50% Exophytic

 6 (46.2)

  • Endophytic

 5 (38.4)
Kidney face location, no. (%)

  • Anterior face

 8 (61.5)

  • Posterior face

 5 (38.4)
Kidney rim location, no. (%)

  • Lateral margin

 9 (69.2)

  • Medial margin

 4 (30.8)
PADUA score, median (IQR) 8 (7–10)
Preoperative score (mg/dL), mean SD 0.87 (0.5)
Preoperative eGFR (ml/min), mean SD—MDRD formula 90.0 (16.4)
Operative time (min), mean (SD) 88.6 (15.0)
Hilar clamping, no. (%)

  • Global ischemia

 4 (30.8)

  • Selective ischemia

 7 (53.8)

  • Clampless

 2 (15.4)
Ischemia time (min), mean (SD)

  • Global ischemia

 19.0 (5.6)

  • Partial ischemia

 25.4 (10.3)
EBL (cc), mean (SD) 193.4 (120.3)
Transfusion rate, no. (%) 1 (7.7)
Extirpative technique, no. (%)

  • Pure enucleation

 4 (30.8)

  • Enucleoresection

 9 (69.2)
Opening collecting system, no. (%)

  • Yes

 4 (30.8)

  • No

 9 (69.2)
Intraoperative complications, no. (%) 0 (0)
Postoperative complications, no. (%) 2 (15.4)
Postoperative complications according to Clavien–Dindo, no. (%)

  • >2

 0 (0)